10바이알 팩재고 624% 할인Retatrutide 5 mg
GLP-1 / GIP / 글루카곤 삼중 작용제 연구 펩타이드
Retatrutide tri-agonist research peptide, Australian-shipped. Lab-verified ≥99% purity.
연구 전용. 이 화합물은 체외 연구 및 실험실 용도로만 판매되며, 인체 섭취나 치료 목적 사용을 의도하지 않습니다. 구매함으로써 귀하가 자격을 갖춘 연구자이며 당사의 전체 면책 조항에 동의하는 것으로 간주됩니다.
6팩만 남음
삼중 수용체 작용제 연구 펩타이드. 대사 연구에서 GLP-1, GIP, 글루카곤 신호 경로에 대한 복합 효과가 검토되었습니다.
Retatrutide is a synthetic tri-agonist research peptide that activates the GLP-1, GIP, and glucagon receptors simultaneously. It is part of a new generation of incretin-receptor research compounds developed to study combined activation of multiple metabolic pathways. Quantum Labs supplies Retatrutide as a lyophilised powder for Australian research applications.
Retatrutide is studied alongside other incretin-receptor agonists — semaglutide (single-agonist GLP-1) and tirzepatide (dual-agonist GLP-1/GIP) — in pre-clinical and clinical research literature. The tri-agonist mechanism is the distinguishing feature that places it in its own research category. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
작용 기전
GLP-1, GIP, 글루카곤 수용체의 동시 작용이 검토되었습니다. 연구는 연구 집단의 대사율, 포만감, 에너지 소비 지표와 관련되어 있습니다.
순도 규격 ≥99%에 대해 HPLC로 검증되었습니다. 인증된 제3자 실험실에서 독립적으로 시험합니다.
Retatrutide — 자주 묻는 질문
What is Retatrutide?
Retatrutide is a synthetic tri-agonist research peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. It is a newer-generation incretin-receptor research compound.
Is Retatrutide legal in Australia?
Retatrutide is not an approved therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Retatrutide for research use only — it is not a substitute for prescription weight-loss medication.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual-agonist activating GLP-1 and GIP receptors. Retatrutide is a tri-agonist activating GLP-1, GIP, and glucagon receptors. The added glucagon-receptor activity is the distinguishing pharmacological feature of Retatrutide.
What is the difference between Retatrutide and Mounjaro?
Mounjaro is the brand name for the approved prescription medicine tirzepatide. Retatrutide is a separate research peptide with an additional glucagon-receptor agonism. They are different molecules studied in parallel research literature. Quantum Labs does not supply prescription medicines.
What is the typical Retatrutide research dosage?
Published clinical research has used Retatrutide doses across a wide titration range. Research-protocol dosing varies by model. Human therapeutic dosing is not established. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
Retatrutide 관련 가이드
연구자들이 함께 살펴보는 항목
10바이알 팩22% 할인MOTS-c
동결건조 분말10 mg · 2 strengths
미토콘드리아 유래 대사 펩타이드
2개 스택에 포함
10바이알 팩17% 할인5-Amino-1MQ
동결건조 분말50 mg · 3 strengths
NNMT 억제제 연구 화합물
10바이알 팩15% 할인L-Carnitine
Sterile solution10 ml × 600 mg/ml
미토콘드리아 지방산 수송 분자
1개 스택에 포함